Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2004 1
2005 1
2006 3
2008 1
2009 2
2010 3
2011 4
2012 6
2013 2
2014 3
2015 3
2016 3
2017 3
2018 5
2019 6
2020 5
2021 4
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Workshop report: Immunoassay standardisation for "universal" influenza vaccines.
Pavlova S, D'Alessio F, Houard S, Remarque EJ, Stockhofe N, Engelhardt OG. Pavlova S, et al. Among authors: engelhardt og. Influenza Other Respir Viruses. 2017 May;11(3):194-201. doi: 10.1111/irv.12445. Epub 2017 Apr 8. Influenza Other Respir Viruses. 2017. PMID: 28146323 Free PMC article. Review.
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study.
Waldock J, Remarque EJ, Zheng L, Ho S, Hoschler K, Neumann B, Sediri-Schön H, Trombetta CM, Montomoli E, Marchi S, Lapini G, Zhou F, Lartey SL, Cox RJ, Facchini M, Castrucci MR, Friel D, Ollinger T, Caillet C, Music N, Palladino G, Engelhardt OG; FLUCOP consortium. Waldock J, et al. Among authors: engelhardt og. Front Immunol. 2023 Apr 18;14:1155552. doi: 10.3389/fimmu.2023.1155552. eCollection 2023. Front Immunol. 2023. PMID: 37143658 Free PMC article.
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement.
Horby PW, Laurie KL, Cowling BJ, Engelhardt OG, Sturm-Ramirez K, Sanchez JL, Katz JM, Uyeki TM, Wood J, Van Kerkhove MD; CONSISE Steering Committee. Horby PW, et al. Among authors: engelhardt og. Influenza Other Respir Viruses. 2017 Jan;11(1):2-14. doi: 10.1111/irv.12411. Epub 2016 Aug 9. Influenza Other Respir Viruses. 2017. PMID: 27417916 Free PMC article.
Current challenges in implementing cell-derived influenza vaccines: implications for production and regulation, July 2007, NIBSC, Potters Bar, UK.
Minor PD, Engelhardt OG, Wood JM, Robertson JS, Blayer S, Colegate T, Fabry L, Heldens JG, Kino Y, Kistner O, Kompier R, Makizumi K, Medema J, Mimori S, Ryan D, Schwartz R, Smith JS, Sugawara K, Trusheim H, Tsai TF, Krause R. Minor PD, et al. Among authors: engelhardt og. Vaccine. 2009 May 14;27(22):2907-13. doi: 10.1016/j.vaccine.2009.02.064. Epub 2009 Feb 27. Vaccine. 2009. PMID: 19366582 Review.
Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.
Ekimov A, Arunachalam AB, Blake T, Bodle J, Couzens L, Dubey S, Eichelberger M, Engelhardt OG, Gubinelli F, Joshi M, Melnyk D, Palladino G, Rigsby P, Rockman S, Savina N, Smith E, Gilchrist SAN; World Health Organization's Pandemic Influenza preparedness, Vaccine Response's Alternative Potency, Reagents Technical Working Group. Ekimov A, et al. Among authors: engelhardt og. Vaccine. 2023 Jul 19;41(32):4639-4647. doi: 10.1016/j.vaccine.2023.06.051. Epub 2023 Jun 19. Vaccine. 2023. PMID: 37344260 Free article.
54 results